These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7190279)

  • 1. Variation in plasma concentrations of clomipramine and desmethylclomipramine during clomipramine therapy.
    Hullin RP
    Postgrad Med J; 1980; 56 Suppl 1():117-9. PubMed ID: 7190279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma concentration of clomipramine and desmethylclomipramine and clinical response in depressed patients.
    Montgomery SA; McAuley R; Montgomery DB; Dawling S; Braithwaite RA
    Postgrad Med J; 1980; 56 Suppl 1():130-3. PubMed ID: 7393823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical trial of a 50 mg formulation of clomipramine (Anafranil) with steady-state plasma level measurements.
    Gringras M; Luscombe DK; Jones RB; Beaumont G; Seldrup J; John V
    J Int Med Res; 1977; 5(1 Suppl):119-24. PubMed ID: 863081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship of plasma clomipramine and N-desmethylclomipramine to response in obsessive-compulsive disorder.
    Mavissakalian M; Jones B; Olson S; Perel JM
    Psychopharmacol Bull; 1990; 26(1):119-22. PubMed ID: 2371366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plasma levels of desmethylclomipramine and clomipramine at steady-state in the morning. Correlative analysis and prediction of theoretical blood clomipramine].
    Champiat JC; Aymard N; des Lauriers A
    Encephale; 1983; 9(1):23-36. PubMed ID: 6872932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic studies in obsessional patients.
    Luscombe DK; Marks IM
    J Int Med Res; 1977; 5 Suppl 5():91-6. PubMed ID: 598610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels and clinical improvement--a comparative study of clomipramine and amitriptyline in depression.
    Moyes IC; Ray RL; Moyes RB
    Postgrad Med J; 1980; 56 Suppl 1():127-9. PubMed ID: 7393822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma level studies with clomipramine (anafranil).
    Jones RB; Luscombe DK
    J Int Med Res; 1977; 5(1 Suppl):98-107. PubMed ID: 863094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma concentrations of clomipramine and desmethylclomipramine in obsessive-compulsive neurosis.
    Luscombe DK; Wright J; Stern RS; Mawson D; Marks IM
    Postgrad Med J; 1980; 56 Suppl 1():140-3. PubMed ID: 7393825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plasma levels of clomipramine and declomipramine in patients with depression: a study of its correlation with therapeutic efficacy].
    Wargny E; Lamiable D; Havet JM; Denis J; Millart H; Choisy H; Pascalis G
    Ann Med Psychol (Paris); 1986 Apr; 144(4):396-406. PubMed ID: 3813333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clomipramine: plasma levels, side effects and outcome in obsessive-compulsive neurosis.
    Stern RS; Marks IM; Wright J; Luscombe DK
    Postgrad Med J; 1980; 56 Suppl 1():134-9. PubMed ID: 7393824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clomipramine and desmethylclomipramine: relationship between plasma levels and clinical effect (author's transl)].
    Vandel B; Vandel S; Jounet JM; Allers G; Volmat R
    Encephale; 1981; 7(5):601-8. PubMed ID: 7327152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug monitoring of clomipramine and desmethylclomipramine in depressed patients using a new liquid chromatographic assay.
    Diquet B; Thomaré P; Bocquentin M; Diviné C
    Biomed Chromatogr; 1993; 7(2):59-63. PubMed ID: 8485374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diurnal profile of melatonin concentrations in patients with major depression: relationship to the clinical manifestation and antidepressant treatment.
    Szymanska A; Rabe-Jablonska J; Karasek M
    Neuro Endocrinol Lett; 2001 Jun; 22(3):192-8. PubMed ID: 11449197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diurnal profile of melatonin secretion in the acute phase of major depression and in remission.
    Rabe-Jabłońska J; Szymańska A
    Med Sci Monit; 2001; 7(5):946-52. PubMed ID: 11535940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of age, cigarette smoking and the oral contraceptive on the pharmacokinetics of clomipramine and its desmethyl metabolite during chronic dosing.
    John VA; Luscombe DK; Kemp H
    J Int Med Res; 1980; 8 Suppl 3():88-95. PubMed ID: 7202824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma level studies of clomipramine and desmethylclomipramine following intravenous infusions of clomipramine in depressive patients.
    Luscombe DK; Wright J; Jain VK
    Postgrad Med J; 1977; 53 Suppl 4():88-96. PubMed ID: 600900
    [No Abstract]   [Full Text] [Related]  

  • 18. Relating plasma levels of clomipramine and clinical response.
    Seldrup J
    J Int Med Res; 1980; 8 Suppl 3():96-110. PubMed ID: 7202825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steady-state plasma levels of clomipramine and its metabolites: impact of the sparteine/debrisoquine oxidation polymorphism. Danish University Antidepressant Group.
    Nielsen KK; Brøsen K; Gram LF
    Eur J Clin Pharmacol; 1992; 43(4):405-11. PubMed ID: 1451721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma concentrations of clomipramine and its N-desmethyl metabolite in depressive patients following treatment with various dosage regimes of clomipramine.
    Jones RB; Luscombe DK
    Postgrad Med J; 1977; 53 Suppl 4():63-76. PubMed ID: 758091
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.